ALSFRS‐R
- 1 September 2004
- journal article
- review article
- Published by Taylor & Francis in Amyotrophic Lateral Sclerosis
- Vol. 5 (sup1), 90-93
- https://doi.org/10.1080/17434470410019906
Abstract
The ALSFRS-R is an attractive primary outcome measure in clinical trials of ALS because it is validated, easy to administer, minimizes dropout, reduces cost, and correlates with survival. Unlike the other standard outcome measures currently employed, the ALSFRS-R is also a measure of global function.Keywords
This publication has 7 references indexed in Scilit:
- Response of Patients With Alzheimer Disease to Rivastigmine Treatment Is Predicted by the Rate of Disease ProgressionArchives of Neurology, 2001
- A controlled trial of recombinant methionyl human BDNF in ALSNeurology, 1999
- Unified Huntington's disease rating scale: A follow upMovement Disorders, 1998
- Intraventricular α-interferon in subacute sclerosing panencephalitisNeurology, 1998
- Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trialsJournal of the Neurological Sciences, 1997
- Amyotrophic Lateral Sclerosis Severity ScaleNeuroepidemiology, 1989